Literature DB >> 16144064

The management of HCV infected pregnant women and their children European paediatric HCV network.

Lucy Pembrey1, Marie-Louise Newell, Pier-Angelo Tovo.   

Abstract

BACKGROUND/AIMS: As evidence accumulates relating to mother-to-child (vertical) transmission of hepatitis C virus (HCV), it is timely to draw up guidelines for the clinical management of HCV infected pregnant women and their children.
METHODS: A review of evidence from the European Paediatric HCV Network (EPHN) prospective study of HCV infected women and their children and other published studies. Meeting of EPHN clinical experts to reach a consensus on recommendations for management. Each recommendation was graded according to the level of evidence. RESULTS/
CONCLUSIONS: Although several risk factors for mother-to-child transmission have been identified, none are modifiable and there are currently no interventions available to prevent vertical transmission of HCV. Data on timing of loss of maternal antibodies and reliability of diagnostic tests inform the optimum follow-up schedule for confirmation or exclusion of infection in children born to HCV infected women. Based on the current evidence, routine antenatal screening for HCV should not be introduced and neither elective caesarean section nor avoidance of breastfeeding should be recommended to HCV infected women to prevent mother-to-child transmission of HCV. HCV/HIV co-infected women should follow existing HIV guidelines.

Entities:  

Mesh:

Year:  2005        PMID: 16144064     DOI: 10.1016/j.jhep.2005.06.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

1.  Mother-to-child transmission of hepatitis C virus infection in Barcelona, Spain: a prospective study.

Authors:  Gemma Claret; Antoni Noguera; Cristina Esteva; Carmen Muñoz-Almagro; Emília Sánchez; Clàudia Fortuny
Journal:  Eur J Pediatr       Date:  2006-12-30       Impact factor: 3.183

Review 2.  What's new in hepatitis C virus infections in children?

Authors:  Malgorzata Pawlowska; Krzysztof Domagalski; Anna Pniewska; Beata Smok; Waldemar Halota; Andrzej Tretyn
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 3.  2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-08-10

Review 4.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 5.  Vertical hepatitis C virus transmission: Main questions and answers.

Authors:  Grazia Tosone; Alberto Enrico Maraolo; Silvia Mascolo; Giulia Palmiero; Orsola Tambaro; Raffaele Orlando
Journal:  World J Hepatol       Date:  2014-08-27

Review 6.  Vertical transmission of hepatitis C virus: Current knowledge and perspectives.

Authors:  Chun-Yan Yeung; Hung-Chang Lee; Wai-Tao Chan; Chun-Bin Jiang; Szu-Wen Chang; Chih-Kuang Chuang
Journal:  World J Hepatol       Date:  2014-09-27

7.  Natural history of vertically acquired HCV infection and associated autoimmune phenomena.

Authors:  Silvia Garazzino; Carmelina Calitri; Antonella Versace; Alda Alfarano; Carlo Scolfaro; Chiara Bertaina; Simona Vatrano; Federica Mignone; Francesco Licciardi; Clara Gabiano; Pier-Angelo Tovo
Journal:  Eur J Pediatr       Date:  2014-03-04       Impact factor: 3.183

Review 8.  Is liver biopsy still needed in children with chronic viral hepatitis?

Authors:  Maria Pokorska-Śpiewak; Barbara Kowalik-Mikołajewska; Małgorzata Aniszewska; Magdalena Pluta; Magdalena Marczyńska
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Managing pediatric hepatitis C: current and emerging treatment options.

Authors:  Wikrom Karnsakul; Mary Kay Alford; Kathleen B Schwarz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

10.  Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil.

Authors:  Zelma B Costa; Gustavo C Machado; Mariza M Avelino; Clidenor Gomes Filho; Jose V Macedo Filho; Ana L Minuzzi; Marilia D Turchi; Mariane M A Stefani; Wayner Vieira de Souza; Celina Mt Martelli
Journal:  BMC Infect Dis       Date:  2009-07-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.